18 research outputs found
Statistical Inference with Multiple Data Sources
In this dissertation, I develop statistical methods to address three important scientific problems. A common theme behind these methods is the stitching together of multiple data sources to address the scientific questions of interest. In the first paper (Chapter 2), I propose a novel statistical framework to learn about the association between a secondary outcome (e.g., obesity) and a genetic risk factor (e.g., ORMDL3 locus on Chromosome 17) from a genetic case-control study based on asthma. The method involves the use of asthma prevalence information from a relevant sample survey. In the second paper (Chapter 3), I develop a method to evaluate whether there are adverse health consequences of kidney donation. To address this question, I use data on donors from the Live Kidney Donors Database from the Johns Hopkins Hospital and on healthy non-donors from the Atherosclerosis Risk in Communities (ARIC) and Coronary Artery Risk Development in Young Adults (CARDIA) studies. In the third paper (Chapter 4), I propose a covariate-adjusted method for testing the difference between two treatment groups where the measured outcome is a function. The proposed method utilizes information from repeated measures of daily oxygen consumption function and scalar body composition measures (e.g., lean mass, fat mass) on two groups mice, one with and one without a specific gene
Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models
Objective: Absolute risk models estimate an individual's future disease risk
over a specified time interval. Applications utilizing server-side risk
tooling, such as the R-based iCARE (R-iCARE), to build, validate, and apply
absolute risk models, face serious limitations in portability and privacy due
to their need for circulating user data in remote servers for operation. Our
objective was to overcome these limitations.
Materials and Methods: We refactored R-iCARE into a Python package (Py-iCARE)
then compiled it to WebAssembly (Wasm-iCARE): a portable web module, which
operates entirely within the privacy of the user's device.
Results: We showcase the portability and privacy of Wasm-iCARE through two
applications: for researchers to statistically validate risk models, and to
deliver them to end-users. Both applications run entirely on the client-side,
requiring no downloads or installations, and keeps user data on-device during
risk calculation.
Conclusions: Wasm-iCARE fosters accessible and privacy-preserving risk tools,
accelerating their validation and delivery.Comment: 10 pages, 2 figure
Recommended from our members
Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry
Abstract: Background: The Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) and the Tyrer-Cuzick breast cancer risk prediction models are commonly used in clinical practice and have recently been extended to include polygenic risk scores (PRS). In addition, BOADICEA has also been extended to include reproductive and lifestyle factors, which were already part of Tyrer-Cuzick model. We conducted a comparative prospective validation of these models after incorporating the recently developed 313-variant PRS. Methods: Calibration and discrimination of 5-year absolute risk was assessed in a nested case-control sample of 1337 women of European ancestry (619 incident breast cancer cases) aged 23–75 years from the Generations Study. Results: The extended BOADICEA model with reproductive/lifestyle factors and PRS was well calibrated across risk deciles; expected-to-observed ratio (E/O) at the highest risk decile :0.97 (95 % CI 0.51 − 1.86) for women younger than 50 years and 1.09 (0.66 − 1.80) for women 50 years or older. Adding reproductive/lifestyle factors and PRS to the BOADICEA model improved discrimination modestly in younger women (area under the curve (AUC) 69.7 % vs. 69.1%) and substantially in older women (AUC 64.6 % vs. 56.8%). The Tyrer-Cuzick model with PRS showed evidence of overestimation at the highest risk decile: E/O = 1.54(0.81 − 2.92) for younger and 1.73 (1.03 − 2.90) for older women. Conclusion: The extended BOADICEA model identified women in a European-ancestry population at elevated breast cancer risk more accurately than the Tyrer-Cuzick model with PRS. With the increasing availability of PRS, these analyses can inform choice of risk models incorporating PRS for risk stratified breast cancer prevention among women of European ancestry
Recommended from our members
Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry
Abstract: Background: The Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) and the Tyrer-Cuzick breast cancer risk prediction models are commonly used in clinical practice and have recently been extended to include polygenic risk scores (PRS). In addition, BOADICEA has also been extended to include reproductive and lifestyle factors, which were already part of Tyrer-Cuzick model. We conducted a comparative prospective validation of these models after incorporating the recently developed 313-variant PRS. Methods: Calibration and discrimination of 5-year absolute risk was assessed in a nested case-control sample of 1337 women of European ancestry (619 incident breast cancer cases) aged 23–75 years from the Generations Study. Results: The extended BOADICEA model with reproductive/lifestyle factors and PRS was well calibrated across risk deciles; expected-to-observed ratio (E/O) at the highest risk decile :0.97 (95 % CI 0.51 − 1.86) for women younger than 50 years and 1.09 (0.66 − 1.80) for women 50 years or older. Adding reproductive/lifestyle factors and PRS to the BOADICEA model improved discrimination modestly in younger women (area under the curve (AUC) 69.7 % vs. 69.1%) and substantially in older women (AUC 64.6 % vs. 56.8%). The Tyrer-Cuzick model with PRS showed evidence of overestimation at the highest risk decile: E/O = 1.54(0.81 − 2.92) for younger and 1.73 (1.03 − 2.90) for older women. Conclusion: The extended BOADICEA model identified women in a European-ancestry population at elevated breast cancer risk more accurately than the Tyrer-Cuzick model with PRS. With the increasing availability of PRS, these analyses can inform choice of risk models incorporating PRS for risk stratified breast cancer prevention among women of European ancestry
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.
We evaluated the joint associations between a new 313-variant PRS (PRS313) and questionnaire-based breast cancer risk factors for women of European ancestry, using 72 284 cases and 80 354 controls from the Breast Cancer Association Consortium. Interactions were evaluated using standard logistic regression and a newly developed case-only method for breast cancer risk overall and by estrogen receptor status. After accounting for multiple testing, we did not find evidence that per-standard deviation PRS313 odds ratio differed across strata defined by individual risk factors. Goodness-of-fit tests did not reject the assumption of a multiplicative model between PRS313 and each risk factor. Variation in projected absolute lifetime risk of breast cancer associated with classical risk factors was greater for women with higher genetic risk (PRS313 and family history) and, on average, 17.5% higher in the highest vs lowest deciles of genetic risk. These findings have implications for risk prevention for women at increased risk of breast cancer
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
Abstract: Genome-wide association studies (GWAS) have led to the identification of hundreds of susceptibility loci across cancers, but the impact of further studies remains uncertain. Here we analyse summary-level data from GWAS of European ancestry across fourteen cancer sites to estimate the number of common susceptibility variants (polygenicity) and underlying effect-size distribution. All cancers show a high degree of polygenicity, involving at a minimum of thousands of loci. We project that sample sizes required to explain 80% of GWAS heritability vary from 60,000 cases for testicular to over 1,000,000 cases for lung cancer. The maximum relative risk achievable for subjects at the 99th risk percentile of underlying polygenic risk scores (PRS), compared to average risk, ranges from 12 for testicular to 2.5 for ovarian cancer. We show that PRS have potential for risk stratification for cancers of breast, colon and prostate, but less so for others because of modest heritability and lower incidence
Statistical Inference with Multiple Data Sources
In this dissertation, I develop statistical methods to address three important scientific problems. A common theme behind these methods is the stitching together of multiple data sources to address the scientific questions of interest. In the first paper (Chapter 2), I propose a novel statistical framework to learn about the association between a secondary outcome (e.g., obesity) and a genetic risk factor (e.g., ORMDL3 locus on Chromosome 17) from a genetic case-control study based on asthma. The method involves the use of asthma prevalence information from a relevant sample survey. In the second paper (Chapter 3), I develop a method to evaluate whether there are adverse health consequences of kidney donation. To address this question, I use data on donors from the Live Kidney Donors Database from the Johns Hopkins Hospital and on healthy non-donors from the Atherosclerosis Risk in Communities (ARIC) and Coronary Artery Risk Development in Young Adults (CARDIA) studies. In the third paper (Chapter 4), I propose a covariate-adjusted method for testing the difference between two treatment groups where the measured outcome is a function. The proposed method utilizes information from repeated measures of daily oxygen consumption function and scalar body composition measures (e.g., lean mass, fat mass) on two groups mice, one with and one without a specific gene
iCARE: An R package to build, validate and apply absolute risk models.
This report describes an R package, called the Individualized Coherent Absolute Risk Estimator (iCARE) tool, that allows researchers to build and evaluate models for absolute risk and apply them to estimate an individual's risk of developing disease during a specified time interval based on a set of user defined input parameters. An attractive feature of the software is that it gives users flexibility to update models rapidly based on new knowledge on risk factors and tailor models to different populations by specifying three input arguments: a model for relative risk, an age-specific disease incidence rate and the distribution of risk factors for the population of interest. The tool can handle missing information on risk factors for individuals for whom risks are to be predicted using a coherent approach where all estimates are derived from a single model after appropriate model averaging. The software allows single nucleotide polymorphisms (SNPs) to be incorporated into the model using published odds ratios and allele frequencies. The validation component of the software implements the methods for evaluation of model calibration, discrimination and risk-stratification based on independent validation datasets. We provide an illustration of the utility of iCARE for building, validating and applying absolute risk models using breast cancer as an example